Allegion (ALLE)

NYSEIndustrialsSecurity & Protection ServicesSnapshot 2026-09-04

$157.12+1.00%

Close 2026-09-04 · 1-day change

Standing thesis

The standing, falsifiable read: what has to stay true, and what would break it.

Compounder

Intact: The reason to own it still holds.

The bull case

Allegion grows revenue about 7% a year and keeps profit margins steady. The company earns about $8.8 per share in 2026 and buys back shares with a $500 million program. It has a strong brand portfolio and stable management. These factors support steady earnings growth.

The bear case

Revenue growth could slow below 7% if demand weakens. Profit margins might shrink due to cost pressures. A downgrade on valuation shows some investor concern. These risks could hurt earnings and share price.

What's priced in

The market expects about 7% revenue growth and values the stock slightly above our estimate of its earnings power. Our view aligns with this but sees risks from margin pressure and demand softness.

What has to stay true

Achieve adjusted EPS near $8.8 in 2026Intact
Management Executionprimary>=8.7 USD per share · FY26 (guidance)
Breaks if: adjusted EPS falls below $8.7 in FY26
Execute share repurchase program up to $500 millionIntact
Capital Allocationsupportingrepurchase program authorized and ongoing · next 4 quarters (qualitative)
Breaks if: share repurchase program is canceled or materially reduced
Sustain revenue growth near 7% annuallyIntact
Revenue Growthprimary>=6% YoY · FY26 (guidance)
Breaks if: YoY revenue growth falls below 6% in FY26

Source: QuarterlyIQ research model· Written 2026-07-08· Health checked 2026-09-04· Version 1· Status: Intact· Reviewed when the evidence changes

This is not a price target or investment advice.

Current Outlook

Week of Sep 5, 2026

A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.

ALLE's long-term thesis remains intact amid mixed sector signals and stable management execution.

What kind of bet this is

This investment represents a durable compounder with a focus on revenue and earnings growth. The current thesis state is stable, supported by management's consistent execution and positive financial performance.

What's priced into Allegion (ALLE)

The market appears to price ALLE as cheap compared to its peers, with a low expectations gap. However, there is some fragility due to weak execution quality, which could affect investor sentiment.

What the fundamentals likely do

Management is on track to increase revenue and adjusted earnings per share (EPS) outlook for 2026, reflecting a positive trajectory. However, there is a moderate risk of missing expectations, given the company's recent history in a high-miss-rate industry.

What Allegion (ALLE) hinges on

The thesis hinges on the performance of sector bellwethers like MSA, BCO, and BRC. If these companies continue to deliver strong results, ALLE could benefit from positive sector momentum; conversely, any weakness could pose a risk.

What changed in the latest read

What changed

The most important moves since the prior daily snapshot.

Short-term · Daily

No material changes since the prior snapshot.

Yes, our read has strengthened. The latest earnings beat strongly reinforces the adjusted EPS outlook. It also confirms an increased revenue growth outlook. There are no new threats impacting the thesis at this time.

as of 2026-09-04

See upcoming information that could change the risk

Review the evidence to watch, what would become a concern, and what would make it less concerning.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.